Australian Clinical Labs Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.416x

Australian Clinical Labs Ltd cash flow conversion efficiency. Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has a cash flow conversion efficiency ratio of 0.416x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$62.87 Million ≈ $44.48 Million USD) by net assets (AU$151.04 Million ≈ $106.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Australian Clinical Labs Ltd (2016–2025)

Cash flow conversion efficiency of Australian Clinical Labs Ltd from 2016 to 2025. This chart illustrates how Australian Clinical Labs Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACL stock price and chart for real-time trading data and today's change.

Australian Clinical Labs Ltd Cash Flow Conversion Ratio Explained

Australian Clinical Labs Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Australian Clinical Labs Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Australian Clinical Labs Ltd ranked by their cash flow conversion efficiency. Also see ACL stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Civeo Corp NYSE:CVEO	0.076x
Magnetic Resources NL AU:MAUCA	-0.681x
Nerdwallet Inc NASDAQ:NRDS	0.126x
Volcon Inc NASDAQ:VLCN	-0.265x
V.S.T Tillers Tractors Limited NSE:VSTTILLERS	0.057x
Aduro Clean Technologies Inc. Common Stock NASDAQ:ADUR	-0.062x
Avidia Bancorp, Inc. NYSE:AVBC	0.023x
Jiangxi Selon Industrial Co Ltd SHE:002748	-0.009x

Annual Cash Flow Conversion Efficiency for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Australian Clinical Labs Ltd from 2016 to 2025. Review Australian Clinical Labs Ltd (ACL) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$171.98 Million ≈ $121.69 Million	AU$182.80 Million ≈ $129.34 Million	1.063x	0.00%
2024-12-31	AU$171.98 Million ≈ $121.69 Million	AU$182.80 Million ≈ $129.34 Million	1.063x	+18.39%
2024-06-30	AU$177.76 Million ≈ $125.78 Million	AU$159.59 Million ≈ $112.92 Million	0.898x	0.00%
2023-12-31	AU$177.76 Million ≈ $125.78 Million	AU$159.59 Million ≈ $112.92 Million	0.898x	+7.89%
2023-06-30	AU$172.67 Million ≈ $122.18 Million	AU$143.68 Million ≈ $101.66 Million	0.832x	0.00%
2022-12-31	AU$172.67 Million ≈ $122.18 Million	AU$143.68 Million ≈ $101.66 Million	0.832x	-31.88%
2022-06-30	AU$232.56 Million ≈ $164.55 Million	AU$284.09 Million ≈ $201.01 Million	1.222x	0.00%
2021-12-31	AU$232.56 Million ≈ $164.55 Million	AU$284.09 Million ≈ $201.01 Million	1.222x	-34.97%
2021-06-30	AU$81.91 Million ≈ $57.96 Million	AU$153.86 Million ≈ $108.87 Million	1.878x	0.00%
2020-12-31	AU$81.91 Million ≈ $57.96 Million	AU$153.86 Million ≈ $108.87 Million	1.878x	+27.37%
2020-06-30	AU$68.99 Million ≈ $48.81 Million	AU$101.74 Million ≈ $71.98 Million	1.475x	0.00%
2019-12-31	AU$68.99 Million ≈ $48.81 Million	AU$101.74 Million ≈ $71.98 Million	1.475x	+3536.33%
2019-06-30	AU$27.42 Million ≈ $19.40 Million	AU$1.11 Million ≈ $786.81K	0.041x	0.00%
2018-12-31	AU$27.42 Million ≈ $19.40 Million	AU$1.11 Million ≈ $786.81K	0.041x	-95.28%
2018-06-30	AU$5.46 Million ≈ $3.86 Million	AU$4.69 Million ≈ $3.32 Million	0.860x	0.00%
2017-12-31	AU$5.46 Million ≈ $3.86 Million	AU$4.69 Million ≈ $3.32 Million	0.860x	+163.80%
2017-06-30	AU$14.12 Million ≈ $9.99 Million	AU$4.60 Million ≈ $3.26 Million	0.326x	0.00%
2016-12-31	AU$14.12 Million ≈ $9.99 Million	AU$4.60 Million ≈ $3.26 Million	0.326x	--

About Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research

Market Cap

$438.21 Million

AU$619.32 Million AUD

Market Cap Rank

#13614 Global

#362 in Australia

Share Price

AU$3.30

Change (1 day)

+1.85%

52-Week Range

AU$1.84 - AU$3.30

All Time High

AU$5.09